- Home
- RCON vs ANL Comparison
RCON vs ANL Comparison
Compare RCON & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- ANL
- Stock Information
- Founded
- RCON 2007
- ANL 2004
- Country
- RCON China
- ANL Cayman Islands
- Employees
- RCON N/A
- ANL N/A
- Industry
- RCON Oilfield Services/Equipment
- ANL
- Sector
- RCON Energy
- ANL
- Exchange
- RCON Nasdaq
- ANL Nasdaq
- Market Cap
- RCON 60.5M
- ANL 51.7M
- IPO Year
- RCON 2009
- ANL 2023
- Fundamental
- Price
- RCON $2.40
- ANL N/A
- Analyst Decision
- RCON
- ANL Hold
- Analyst Count
- RCON 0
- ANL 1
- Target Price
- RCON N/A
- ANL N/A
- AVG Volume (30 Days)
- RCON 293.8K
- ANL 8.0K
- Earning Date
- RCON 07-15-2025
- ANL 08-08-2025
- Dividend Yield
- RCON N/A
- ANL N/A
- EPS Growth
- RCON N/A
- ANL N/A
- EPS
- RCON N/A
- ANL N/A
- Revenue
- RCON $8,996,572.00
- ANL N/A
- Revenue This Year
- RCON N/A
- ANL N/A
- Revenue Next Year
- RCON $12.17
- ANL N/A
- P/E Ratio
- RCON N/A
- ANL N/A
- Revenue Growth
- RCON N/A
- ANL N/A
- 52 Week Low
- RCON $1.35
- ANL $1.10
- 52 Week High
- RCON $3.70
- ANL $4.10
- Technical
- Relative Strength Index (RSI)
- RCON 51.61
- ANL 43.16
- Support Level
- RCON $2.38
- ANL $1.48
- Resistance Level
- RCON $2.75
- ANL $1.57
- Average True Range (ATR)
- RCON 0.32
- ANL 0.08
- MACD
- RCON -0.02
- ANL 0.01
- Stochastic Oscillator
- RCON 44.44
- ANL 29.41
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.